TIMP4 and breast carcinoma: First, in contrast to early reports on the antitumoral function of TIMP-4 on breast cancer tumor growth and invasion [84], Jiang et al. reported that systemic delivery of TIMP-4 stimulated breast cancer tumorigenesis [85].